An Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in casualty insurance, providing for coverage for treatments to slow the progression of Alzheimer's disease and related dementias.

Pennsylvania House Bill 2734 requires health insurance companies to cover FDA-approved diagnostic tests and treatments that slow the progression of Alzheimer's disease and related dementias. The mandate applies to insurers offering individual or group health policies in the state, with a compliance deadline of January 1, 2028, unless federal law preempts the requirement. The bill explicitly prohibits insurers from using step therapy for these specific treatments, meaning patients cannot be forced to try other medications first before receiving coverage for approved Alzheimer's therapies.